About Dr Rob

Dr Rob Weiss, MBBS — AHPRA GP Specialist focused on precision health optimisation and longevity education.

Rob is a highly experienced General Practitioner now focusing on individualised precision health, preventive health education, biological age markers and practical healthspan planning.

Dr Rob Weiss

Clinical focus

His current clinical practice is centred on non-surgical treatments, including the application of metabolic peptides such as GLP-1 receptor agonists and advanced musculoskeletal care.

At the clinic, Dr Rob employs Platelet Rich Plasma therapy for the non-surgical treatment of acute and chronic musculoskeletal conditions, including osteoarthritis, tendinopathies and sports injuries.

Precision health interests

Working with motivated patients has led Rob to move beyond standard care into emerging therapies, longevity education and practical health optimisation strategies.

His areas of interest include HIIT, Zone 2 training, intermittent fasting, heat and cold shock therapies, hyperbaric oxygen therapy, healthy ageing education and microbiome health.

Professional background

Education and clinical experience.

Dr Weiss graduated MBBS from the University of Melbourne in 1981 and completed residency training at Alfred Hospital Melbourne and Georgetown University in Washington DC.

He practised as owner and practice principal of a four-doctor clinic in Frankston, Victoria from 1997 to 2022, and is registered as a GP Specialist with AHPRA.

Leadership and education

Senior advisory, liaison and training roles.

Dr Weiss has held senior advisory, liaison and educational roles with Victorian government groups and primary health networks, reflecting his commitment to medical policy, training and patient education.

Member of the Victorian Government Schedule 8 Poisons Review Committee in 2014.

Inaugural member of the DOHA Healthcare Homes program from 2017 to 2022.

Member of the Australian Society Hepatitis Medicine and the Hepatitis C Eradication Group in 2013.

Committee and advisory roles with SEMPHN, including contingency planning, Covid-19 emergency response and family violence pathways resources.

Mentorship and training roles for GPs through RACGP and SEMPHN, plus medical student training with the University of Melbourne.

Research credentials

Published peer-reviewed clinical research.

Dr Weiss maintains a commitment to clinical research and is an author on multiple published peer-reviewed clinical research papers, including work in hepatitis C care and opioid-dependence treatment models.

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence.

View research

Provider costs of treating opioid dependence with extended-release buprenorphine in Australia.

View research

HCV in the Australian primary care setting: real-world effectiveness of 12 weeks of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C.

View research

A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia.

View research

Considerations for delivering extended-release buprenorphine for opioid dependence in Australia: preliminary lessons from the Community Long-Acting Buprenorphine trial.

View research

Patient education

Rob’s interest in research and education has led to the production of numerous educational materials for patients to access, helping doctor and patient collaborate more effectively around precision health, healthspan planning and preventive health education.

This page is educational and biographical. It does not replace an individual medical consultation or provide emergency care.